ProQR Therapeutics

^{Priced, Nasdaq: PRQR}

Preclinical Dutch biotech developing an mRNA repair therapy for cystic fibrosis.

Industry: Health Care

First Day Return: +13.3%

PRQR

Preclinical Dutch biotech developing an mRNA repair therapy for cystic fibrosis.

IPO News for ProQR Therapeutics

US IPO Pricing Recap: Alibaba pops 38%, represents one third of 2014 IPO market proceeds 09/19/14
ProQR Therapeutics prices upsized IPO at $13, the high end of the range 09/18/14
Alibaba and 6 health care IPOs planned for the week of September 15 09/15/14

IPO Data
IPO Date	09/17/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$98
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.proqr-tx.com
Headquarters	Leiden, Netherlands
Founded	2012
Employees at IPO	45

IPO News for ProQR Therapeutics

ProQR Therapeutics (PRQR) Performance